X
02Dec

UK Life Sciences and Healthcare Newsletter - December 2020: The UK National Security and Investment Bill

Dechert LLP | | Return|
The UK has announced a bill proposing a new system to screen transactions for national security risk, separate from the system of merger review operated by the Competition and Markets Authority. The National Security and Investment Bill has been in the pipeline since the publication of the National Security Risk Assessment in 2015, but has been delayed due to Brexit and the COVID-19 pandemic....
By: Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-53811/

Related

Chancery Court Honors Shareholder Representative Provision Holding Selling Stockholders Are Not Real Parties-In-Interest

In Fortis Advisors LLC, v. Allergan W.C. Holding Inc., C.A. No. 2019-0159-NTZ (Del. Ch. May 14, 2020...

Read More >

Pensions: What's new this week - 19 August

Welcome to your weekly update from the Allen & Overy Pensions team, bringing you up to speed on the ...

Read More >

MFS is latest proprietary fund settlement

Massachusetts Financial Services Co. (MFS) has reached a settlement of nearly $7 million in a lawsui...

Read More >

Navigating Governmental Stay At Home Orders in Connection with Construction of Energy Projects

In the rapidly evolving landscape of COVID-19 response, many states, counties, and cities throughout...

Read More >

Court of Appeal declares Heathrow expansion unlawful on climate change grounds

In its recent decision in R. v Secretary of State for Transport, the Court of Appeal ruled that the ...

Read More >

The Coronavirus and M&A Transactions: MAE Clauses

In late 2019, COVID-19 (more commonly known as the coronavirus) began to spread throughout mainland ...

Read More >